pirinixic acid has been researched along with Hyperlipemia in 6 studies
pirinixic acid: structure
| Excerpt | Relevance | Reference |
|---|---|---|
| "(-)DRF 2725 (6) is a phenoxazine analogue of phenyl propanoic acid." | 1.31 | (-)3-[4-[2-(Phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic acid [(-)DRF 2725]: a dual PPAR agonist with potent antihyperglycemic and lipid modulating activity. ( Bajji, AC; Chakrabarti, R; Juluri, S; Kalchar, S; Lohray, BB; Lohray, VB; Mamidi, NV; Misra, P; Padakanti, S; Poondra, RR; Rajagopalan, R; Vikramadithyan, RK, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Willson, TM | 1 |
| Brown, PJ | 1 |
| Sternbach, DD | 1 |
| Henke, BR | 1 |
| Lohray, BB | 1 |
| Lohray, VB | 1 |
| Bajji, AC | 1 |
| Kalchar, S | 1 |
| Poondra, RR | 1 |
| Padakanti, S | 1 |
| Chakrabarti, R | 1 |
| Vikramadithyan, RK | 1 |
| Misra, P | 1 |
| Juluri, S | 1 |
| Mamidi, NV | 1 |
| Rajagopalan, R | 1 |
| Fiamoncini, J | 1 |
| Lima, TM | 1 |
| Hirabara, SM | 1 |
| Ecker, J | 1 |
| Gorjão, R | 1 |
| Romanatto, T | 1 |
| ELolimy, A | 1 |
| Worsch, S | 1 |
| Laumen, H | 1 |
| Bader, B | 1 |
| Daniel, H | 1 |
| Curi, R | 1 |
| Ringseis, R | 1 |
| Keller, J | 1 |
| Lukas, I | 1 |
| Spielmann, J | 1 |
| Most, E | 1 |
| Couturier, A | 1 |
| König, B | 1 |
| Hirche, F | 1 |
| Stangl, GI | 1 |
| Wen, G | 1 |
| Eder, K | 1 |
| Fu, J | 1 |
| Oveisi, F | 1 |
| Gaetani, S | 1 |
| Lin, E | 1 |
| Piomelli, D | 1 |
| Staels, B | 1 |
| Koenig, W | 1 |
| Habib, A | 1 |
| Merval, R | 1 |
| Lebret, M | 1 |
| Torra, IP | 1 |
| Delerive, P | 1 |
| Fadel, A | 1 |
| Chinetti, G | 1 |
| Fruchart, JC | 1 |
| Najib, J | 1 |
| Maclouf, J | 1 |
| Tedgui, A | 1 |
1 review available for pirinixic acid and Hyperlipemia
| Article | Year |
|---|---|
The PPARs: from orphan receptors to drug discovery.
Topics: Animals; Diabetes Mellitus; Drug Design; Humans; Hyperlipidemias; Hypertension; Inflammation; Ligand | 2000 |
5 other studies available for pirinixic acid and Hyperlipemia
| Article | Year |
|---|---|
(-)3-[4-[2-(Phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic acid [(-)DRF 2725]: a dual PPAR agonist with potent antihyperglycemic and lipid modulating activity.
Topics: Animals; Biological Availability; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Hyperlip | 2001 |
Medium-chain dicarboxylic acylcarnitines as markers of n-3 PUFA-induced peroxisomal oxidation of fatty acids.
Topics: Animals; Biomarkers; Carnitine; Diet, High-Fat; Dietary Fats; Dietary Fats, Unsaturated; Fatty Acids | 2015 |
Treatment with pharmacological PPARα agonists stimulates the ubiquitin proteasome pathway and myofibrillar protein breakdown in skeletal muscle of rodents.
Topics: Animals; Anticholesteremic Agents; Clofibrate; Humans; Hyperlipidemias; Mice; Mice, Knockout; Muscle | 2013 |
Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats.
Topics: Animals; Body Weight; Butyrates; CD36 Antigens; Cholesterol; Coenzyme A Ligases; Eating; Endocannabi | 2005 |
Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.
Topics: Acute-Phase Proteins; Animals; Anti-Inflammatory Agents; Aorta; Coronary Disease; COS Cells; Cycloox | 1998 |